Delivery Order SPE2DB20D2002-SPE2DB25FL60Q
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $67,678.99 for 60-count tablets of Multaq 400 mg on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, representing a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,947.74 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, supporting the military...
- The Defense Logistics Agency awarded a $4,266.63 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of June 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $4,435.36. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award. The contract is scheduled for ultimate completion on August 6, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,234.92 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-unit package). This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the management of atrial fibrillation, representing a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,368.45 for 60-tablet units of Multaq 400 mg on June 13, 2025, with completion scheduled for June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in cardiac care, reflecting the pharmaceutical supply requirements...
- The Defense Logistics Agency awarded a delivery order valued at $10,061.44 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Multaq is a cardiovascular medication used in the treatment of atrial fibrillation, reflecting the...
- The Defense Logistics Agency awarded a $11,457.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 9, 2025, with a completion date of September 10, 2025. This competitive award with firm fixed pricing represents a pharmaceutical supply delivery under a child contract arrangement. Multaq (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation, reflecting the company's role as a critical pharmaceutical supplier for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...